Search research articles
Contact Us
Filters
Showing results (91-100 of 170) with videos related to
Page
of 17
Sort By:
Asia-Pacific Journal of Clinical Oncology
|
September 24, 2020
Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease
Andrew Schmidt, Angelyn Anton, Julia Shapiro, et al.
BJUI Compass
|
May 2, 2022
Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
Angelyn Anton, Sruti Pillai, Marie Christine Semira, et al.
Clinical & Translational Immunology
|
September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survival
Rosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index
Daphne Day, Christina Guo, Yada Kanjanapan, et al.
European Urology Open Science
|
October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
Cristian Udovicich, Jason Callahan, Mathias Bressel, et al.
British Journal of Cancer
|
May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
Anthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
Lewis Au, Natalie Turner, Hui-Li Wong, et al.
BJU International
|
October 8, 2021
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer
Richard Kelly, Angelyn Anton, Shirley Wong, et al.
Genomics
|
April 23, 2013
Clinical genomics information management software linking cancer genome sequence and clinical decisions
Stuart Watt, Wei Jiao, Andrew M K Brown, et al.
European Urology Oncology
|
October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 170) with videos related to
Sort By:
Page
of 17
Asia-Pacific Journal of Clinical Oncology
|
September 24, 2020
Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease
Andrew Schmidt, Angelyn Anton, Julia Shapiro, et al.
BJUI Compass
|
May 2, 2022
Real-world first-line systemic therapy patterns in metastatic castration-resistant prostate cancer
Angelyn Anton, Sruti Pillai, Marie Christine Semira, et al.
Clinical & Translational Immunology
|
September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survival
Rosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
JNCI Cancer Spectrum
|
April 28, 2020
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index
Daphne Day, Christina Guo, Yada Kanjanapan, et al.
European Urology Open Science
|
October 3, 2022
Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma
Cristian Udovicich, Jason Callahan, Mathias Bressel, et al.
British Journal of Cancer
|
May 26, 2023
Phase 1 study of GSK3368715, a type I PRMT inhibitor, in patients with advanced solid tumors
Anthony B El-Khoueiry, James Clarke, Tobias Neff, et al.
Asia-Pacific Journal of Clinical Oncology
|
March 17, 2017
How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia?
Lewis Au, Natalie Turner, Hui-Li Wong, et al.
BJU International
|
October 8, 2021
Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer
Richard Kelly, Angelyn Anton, Shirley Wong, et al.
Genomics
|
April 23, 2013
Clinical genomics information management software linking cancer genome sequence and clinical decisions
Stuart Watt, Wei Jiao, Andrew M K Brown, et al.
European Urology Oncology
|
October 8, 2023
Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502)
Andrew Weickhardt, Farshad Foroudi, Nathan Lawrentschuk, et al.
Page
of 17